Retrospective analysis of growth hormone effects on growth and adenoma volume in children with pituitary microadenoma

High Risk Stocks To Buy 2017 【720p】

: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles

: 2017 favored growth investors; U.S. growth stocks returned roughly 29.59%, more than double the 13.19% return of value stocks. 10 High-Risk, High-Reward Stocks to Buy for 2017

The following stocks represented some of the most successful speculative plays for the year: high risk stocks to buy 2017

: Stocks like Freeport-McMoRan (FCX) and Cameco (CCJ) were considered high-risk due to volatile commodity prices. FCX, in particular, was viewed as a speculative "survival" play as it wrestled with high debt levels relative to cash flow.

: Expectations of tax cuts and increased infrastructure support under the new U.S. administration provided a tailwind for industrial and homebuilding stocks like Boeing (BA) and D.R. Horton (DHI) . : A high-beta tech play that gained 109%

Success in 2017 often depended on identifying specific catalysts within high-risk industries:

: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data. 10 High-Risk, High-Reward Stocks to Buy for 2017

: The maker of Invisalign benefited from a near-monopoly on invisible braces, seeing a 131% increase as it expanded its training to thousands of dentists globally.